I am an assistant attending physicist in the Department of Medical Physics with certification from the American Board of Radiology and a license from the state of New York. My clinical research focuses on using image guidance systems to track patient motion in treatment planning and to improve the precision of radiation treatment delivery.
In particular, I am interested in combining three- and four-dimensional optical surface imaging with internal imaging techniques such as CT, MRI, and PET to develop biomechanical and biostatistical models that can predict and verify the position of a targeted tumor and organ motion.
I have established four clinical research programs for patients with brain, head and neck, and breast cancers. In these programs, we are studying radiation therapy techniques such as frameless stereotactic radiosurgery, stereotactic body radiotherapy, and other novel clinical procedures to more effectively target radiation to tumors and spare healthy tissue.
In another research program, we are evaluating ways to account for the effect of breathing on tumor position in patients with lung, liver, and pancreatic cancer.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Guang Li discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures